{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:00:35Z","timestamp":1790834435939,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.transci.2026.104434","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:52:48Z","timestamp":1776959568000},"page":"104434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A changing donor landscape revealed by 12.5 years of residual risk estimates of TTIs using the NAT-yield\/window period model with public health cost rationale for scale-up in India"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-6871","authenticated-orcid":false,"given":"Rasika Dhawan","family":"Setia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitu","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyasha","family":"Prajapat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amena Ebadur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2026.104434_bib1","unstructured":"National Action Plan Combating Viral Hepatitis in India. Retrieved December 6, 2025, from \u3008https:\/\/nvhcp.mohfw.gov.in\/common_libs\/Operational_Guidelines.pdf\u3009."},{"key":"10.1016\/j.transci.2026.104434_bib2","unstructured":"National AIDS Control Organization. Ministry of Health and Family Welfare, Government of India: HIV Facts & figures. Retrieved December 6, 2025,from: \u3008http:\/\/www.naco.gov.in\/hiv-facts-figures\u3009."},{"key":"10.1016\/j.transci.2026.104434_bib3","unstructured":"Worldometer (n.d.). Current world population. Retrieved December 6, 2025, from \u3008https:\/\/www.worldometers.info\/world-population\/\u3009."},{"key":"10.1016\/j.transci.2026.104434_bib4","series-title":"Technical Manual. Directorate General Health Services (DGHS).","first-page":"370","author":"Transfusion Medicine","year":"2022"},{"key":"10.1016\/j.transci.2026.104434_bib5","first-page":"397","article-title":"Seroprevalence and trend of HBV, HCV, and HIV infections among blood donors of Fars Province, Iran (2006-2018)","volume":"30","author":"Azadbakht","year":"2020","journal-title":"Ethiop J Health Sci"},{"key":"10.1016\/j.transci.2026.104434_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1537-2995.2010.02804.x","article-title":"Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms","volume":"51","author":"Weusten","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2026.104434_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.7861\/clinmed.2022-0401","article-title":"Challenges for the maintaining the microbiological safety of the UK blood supply","volume":"23","author":"Neuberger","year":"2023","journal-title":"Clin Med"},{"key":"10.1016\/j.transci.2026.104434_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/IJPM.IJPM_361_16","article-title":"Nucleic acid amplification testing in Indian blood banks: a review with perspectives","volume":"60","author":"Ghosh","year":"2017","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.transci.2026.104434_bib9","first-page":"10","article-title":"Experience of blood donor screening by individual donor nucleic acid testing and reduction of residual risk of transfusion-transmitted viral infections: a 16-year review","author":"Chowdhry","year":"2025","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.transci.2026.104434_bib10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4103\/0971-5916.160687","article-title":"Repeat voluntary non-remunerated blood donor is the best quality indicator for blood safety","volume":"141","author":"Nair","year":"2015","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.transci.2026.104434_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/19317611.2023.2286984","article-title":"Prevalence and predictors of risky sexual behavior among young men in India: evidence from National Family Health Survey","volume":"36","author":"Chandra","year":"2024","journal-title":"Int J Sex Health"},{"key":"10.1016\/j.transci.2026.104434_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/GJTM.GJTM_52_17","article-title":"Paradigm shift of high-risk sexual behavior among Indian blood donors: a threat to blood recipients","volume":"3","author":"Mangwana","year":"2018","journal-title":"Glob J Transfus Med"},{"key":"10.1016\/j.transci.2026.104434_bib13","series-title":"Technical Manual. Directorate General Health Services (DGHS)","first-page":"37","author":"Transfusion Medicine","year":"2022"},{"key":"10.1016\/j.transci.2026.104434_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1537-2995.2004.04215.x","article-title":"A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors","volume":"45","author":"Busch","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2026.104434_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1537-2995.2010.02804.x","article-title":"Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms","volume":"51","author":"Weusten","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2026.104434_bib16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1537-2995.2007.01108.x","article-title":"Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services","volume":"47","author":"O'Brien","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2026.104434_bib17","unstructured":"cobas \u00ae MPX Multiplex HIV, HCV & HBV nucleic acid test for use on the cobas \u00ae 6800\/8800 Systems. Retrieved December 6, 2025, from: \u3008https:\/\/www.fda.gov\/media\/115031\/download\u3009."},{"key":"10.1016\/j.transci.2026.104434_bib18","unstructured":"WHO Expert Committee on Biological Standardization. Guidelines on estimation of residual risk of HIV, HBV or HCV infections via cellular blood components and plasma. 2017. Retrieved December 6, 2025, from: \u3008https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/blood-products\/document-migration\/resriskgl_who_trs_1004_web_annex_4.pdf?sfvrsn=55dd09d3_3\u3009."},{"key":"10.1016\/j.transci.2026.104434_bib19","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/cid\/ciad455","article-title":"Timely diagnosis of incubating syphilis infections using Treponema pallidum transcription-mediated amplification assay","volume":"77","author":"Zondag","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transci.2026.104434_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/JBM.S189079","article-title":"Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the regional blood transfusion center of Ouagadougou, Burkina Faso","volume":"10","author":"Yooda","year":"2019","journal-title":"J Blood Med"},{"key":"10.1016\/j.transci.2026.104434_bib21","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"key":"10.1016\/j.transci.2026.104434_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4103\/ijph.IJPH_356_19","article-title":"Cost of treatment and consequences for chronic hepatitis B and C virus infection at a tertiary care hospital in Delhi","volume":"64","author":"Balasundaram","year":"2020","journal-title":"Indian J Public Health"},{"key":"10.1016\/j.transci.2026.104434_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/vox.12543","article-title":"Health economics and outcomes working group & collaborators. An assessment of differences in costs and health benefits of serology and NAT screening of donations for blood transfusion in different Western countries","volume":"112","author":"Janssen","year":"2017","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2026.104434_bib24","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1080\/21645515.2020.1847951","article-title":"Prevalence and factors associated with hepatitis B virus infection among household members: a cross-sectional study in Beijing","volume":"17","author":"Zhao","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.transci.2026.104434_bib25","unstructured":"Government of India, Ministry of Health and Family Welfare, Department of AIDS Control. (2014). Guidelines for Recovery of Processing Charges for Blood and Blood Components-reg. (F No. No.S.12016\/01\/2012-NACO(NBTC)). Retrieved December 6, 2025, from \u3008https:\/\/naco.gov.in\/sites\/default\/files\/Guidelines%20on%20recovery%20of%20Processing%20Charges%20for%20Blood%20%26%20Blood%20Components.pdf\u3009."},{"key":"10.1016\/j.transci.2026.104434_bib26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/tme.12923","article-title":"Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield\/window period model in an Indian setting","volume":"32","author":"Pandey","year":"2022","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2026.104434_bib27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1537-2995.2009.02110.x","article-title":"Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa","volume":"49","author":"Vermeulen","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2026.104434_bib28","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/trf.13017","article-title":"Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan","volume":"55","author":"Niazi","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2026.104434_bib29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tracli.2017.06.020","article-title":"Fifteen years of nucleic acid testing in France: results and lessons","volume":"24","author":"Laperche","year":"2017","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.transci.2026.104434_bib30","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/trf.13106","article-title":"Failure of self-disclosure of deferrable risk behaviors associated with transfusion-transmissible infections in blood donors","volume":"55","author":"Wong","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2026.104434_bib31","first-page":"407","article-title":"Sexual behaviour of Croatian blood donors as a threat to the health of blood recipients","volume":"9","author":"Miskulin","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2026.104434_bib32","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1046\/j.1537-2995.2001.41121480.x","article-title":"Risk behavior in Norwegian blood donors","volume":"41","author":"Stigum","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2026.104434_bib33","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/trf.12554","article-title":"Understanding noncompliance with selective donor deferral criteria for high-risk behaviors in Australian blood donors","volume":"54","author":"Lucky","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2026.104434_bib34","unstructured":"World Health Organization. Towards 100% voluntary blood donation: a global framework for action [Internet]. www.who.int. 2010. Retrieved December 6, 2025, from \u3008https:\/\/www.who.int\/publications\/i\/item\/9789241599696\u3009."},{"key":"10.1016\/j.transci.2026.104434_bib35","unstructured":"JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee Position Statement [Internet]. 2024. Retrieved December 6, 2025,from:: \u3008https:\/\/www.transfusionguidelines.org\/document-library\/documents\/jpac-position-statement-on-residual-risk-september-2024\/download-file\/JPAC%20Position%20Statement%20on%20Residual%20Risk%20-%20September%202024.pdf\u3009."},{"key":"10.1016\/j.transci.2026.104434_bib36","first-page":"409","article-title":"Prevalence, incidence and residual risk of transfusion-transmitted hepatitis B virus infection in Italy from 2009 to 2018","volume":"17","author":"Velati","year":"2019","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2026.104434_bib37","unstructured":"India Historical Inflation Rates-2014\u20132025. Retrieved December 6, 2025,from: \u3008https:\/\/www.rateinflation.com\/inflation-rate\/india-historical-inflation-rate\/\u3009."},{"key":"10.1016\/j.transci.2026.104434_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/2394-7438.174841","article-title":"Liver transplant scene in India","volume":"2","author":"Soin","year":"2016","journal-title":"MAMC J Med Sci"},{"key":"10.1016\/j.transci.2026.104434_bib39","unstructured":"Acharya M. World GDP Ranking 2025 List. cleartax. 2025. Retrieved December 6, 2025,from: \u3008https:\/\/cleartax.in\/s\/world-gdp-ranking-list\u3009."}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:35:37Z","timestamp":1781105737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050226000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1473050226000662"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104434","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A changing donor landscape revealed by 12.5 years of residual risk estimates of TTIs using the NAT-yield\/window period model with public health cost rationale for scale-up in India","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104434"}}